nasdaq edit stock forecast
According to the issued ratings of 11 analysts in the last year the consensus rating for Editas Medicine stock is Hold based on the current 2 sell ratings 4 hold ratings and 5. Value at the end 15082 change for August 400.
2 hours agoInflation dominated headlines this week with the Consumer Price Index rising 85 in March -- its highest year-over-year expansion in 2022 so.
. EDIT EDITAS MEDICINEs current Earnings Per Share EPS is -285. During the day the stock fluctuated 309 from a day low at 72500 to a day high of 74742. Erictaylor Pro Jan 11.
Editas Medicine stock price prediction is an act of determining the future value of Editas Medicine shares using few different conventional methods such as EPS estimation analyst consensus or fundamental intrinsic valuation. The company reported 013 earnings per share EPS for the quarter beating the consensus estimate of 017 by 004. Editas Medicine Inc.
Related
022 13 DATA AS. Adobe NASDAQ. This is what breakout trading is about.
ARQT Arcutis Biotherapeuticss current Earnings Per Share EPS is -418. ADBE Shares of Adobe have been swept up in the tech sector selloff and have tanked 244 year-to-date even as the software company delivered upbeat Q1 FY22 results. The price has risen in 7 of the last 10 days and is up by 867 over the past 2 weeks.
The successful prediction of Editas Medicines future price could yield a significant profit. USD 1613 116 671. Volume has increased on the last day along with the price which is a positive technical sign and in total 187 thousand more shares were traded than the day before.
View Quantum-Sis earnings history. Price as of April 7 2022 400 pm. Results and further company plans will be out to the public.
Since breakout we go small rejection at 73 however this is the biggest moment. The biotech holds exclusive rights to. Stock Price Forecast The 13 analysts offering 12-month price forecasts for Editas Medicine Inc have a median target of 2700 with a high estimate of 8000 and a low estimate of 1000.
Maximum value 15987 while minimum 14177. With the companys and energy sectors success in 2021 some investors may be wondering if the company is a good long. On average analysts forecast that KMPHs EPS will be -006 for 2022 with the lowest EPS forecast at -025 and the highest EPS forecast at 013.
NTES NETEASEs forecast annual earnings growth rate of 764 is not forecast to beat the US Internet Content Information industrys average forecast earnings growth rate of 965 and while it is not forecast to beat the US markets average forecast earnings growth rate of. Quantum-Si incorporated NASDAQQSI announced its earnings results on Thursday November 11th. End of the year for edit seems extremely positive.
Editas Medicine is a pioneer in gene editing technology. With a 5-year investment the revenue is expected to be around 6712. Find the latest Editas Medicine Inc.
On average analysts forecast that ARQTs EPS will be -551 for 2022 with the lowest EPS forecast at -621 and the highest EPS forecast at -466. 26 rows NASDAQ predictions for August 2023. This company should be massive but as of.
KMPH Kempharms current Earnings Per Share EPS is -211. Stock Price Forecast The 13 analysts offering 12-month price forecasts for Editas Medicine Inc have a median target of 2700 with a high estimate of 8000 and a low estimate of 1000. Averaged NASDAQ value for month 14937.
This is exactly what edit is doing. Based on our forecasts a long-term increase is expected the EDIT stock price prognosis for 2027-04-09 is 31335 USD. The forecast for beginning of August 14502.
ET View Interactive EDIT Charts. Working on cure for blindness as well as positive tumor shrinking results. Common Stock EDIT Stock Quotes - Nasdaq offers stock quotes market activity data for US and global markets.
You wait for a confirmed backtest hold of previous resiatnce as support you wait for a bounce with some confirmed volume. EDIT stock quote history news and other vital information to help you with your stock trading and investing. 4 hours agoIn the past year alone the companys stock price has increased by over 51.
Common Stock EDIT Nasdaq Listed. On average analysts forecast that EDITs EPS will be -324 for 2022 with the lowest EPS forecast at -375 and the highest EPS forecast at -273. Data is currently not available.
What Are The Best Stocks To Invest In 5 Gene Editing Stocks To Watch Now Nasdaq
Edit Editas Medicine Inc Stock Overview U S Nasdaq Barron S
Edit Stock Price And Chart Nasdaq Edit Tradingview
Edit Stock Price And Chart Nasdaq Edit Tradingview
Why Crispr Therapeutics Stock Sank 50 5 In 2021 And Continues To Fall Nasdaq
This Insider Has Just Sold Shares In Editas Medicine Inc Nasdaq Edit Nasdaq
Edit Editas Medicine Inc Stock Overview U S Nasdaq Barron S
Edit Editas Medicine Inc Stock Overview U S Nasdaq Barron S
3 Stock Market Predictions For Another Year Like No Other Nasdaq
My 3 Biggest Stock Market Predictions For January Nasdaq
Edit Stock Price And Chart Nasdaq Edit Tradingview
Edit Stock Price And Chart Nasdaq Edit Tradingview
Stock Market Price List Background Investment Stock Photo Edit Now 561378739
What Are Our Analysts Stock Market Predictions For 2021 Ig Bank Switzerland
Analyst Stock Forecast Change Nasdaq
Macro Closeup Blue Background Stock Chart Stock Photo Edit Now 1045830916
Volatility Of Stock Price Index For Indonesia Ddsm01ida066nwdb Fred St Louis Fed
Where Will Editas Medicine Be In 5 Years Nasdaq
Edit Stock Price And Chart Nasdaq Edit Tradingview
